Clinical Trial Update: Evaluate RLS-1496 Topical Cream for Actinic Keratosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating a topical cream called RLS-1496 for actinic keratosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• RLS-1496 topical cream (RLS-1496)

Snippet

Sponsor: Rubedo Life Sciences, Inc. | Conditions: Actinic Keratosis (AK) | Phase 1, Phase 2 | Status: RECRUITING